• FluoGuide entered a non-exclusive collaboration with Leica Microsystems to support development of its FG001 imaging agent in brain tumor surgery.
• Work targets clinical-phase support in high-grade glioma, optimizing use of Leica microscope imaging systems with FG001.
• Agreement includes no upfront payment; terms were not disclosed.
• Management expects no impact on 2026 financial results.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fluoguide A/S published the original content used to generate this news brief on October 02, 2026, and is solely responsible for the information contained therein.